Literature DB >> 12181162

NSAIDs counteract H. pylori VacA toxin-induced cell vacuolation in MKN 28 gastric mucosal cells.

Vittorio Ricci1, Barbara A Manzo, Concetta Tuccillo, Patrice Boquet, Ulderico Ventura, Marco Romano, Raffaele Zarrilli.   

Abstract

The relationship between nonsteroidal anti-inflammatory drugs (NSAIDs) and Helicobacter pylori-induced gastric mucosal injury is still under debate. VacA toxin is an important H. pylori virulence factor that causes cytoplasmic vacuolation in cultured cells. Whether and how NSAIDs affect VacA-induced cytotoxicity is unclear. This study was designed to evaluate the effect of NSAIDs on H. pylori VacA toxin-induced cell vacuolation in human gastric mucosal cells in culture (MKN 28 cell line). Our data show that 1) NSAIDs (indomethacin, aspirin, and NS-398) inhibit VacA-induced cell vacuolation independently of inhibition of cell proliferation and prostaglandin synthesis; 2) NSAIDs impair vacuole development/maintenance without affecting cell binding and internalization of VacA; and 3) NSAIDs, as well as the chloride channel blocker 5-nitro-2-(3-phenylpropylamino) benzoic acid, also inhibit cell vacuolation induced by ammonia. We thus hypothesize that NSAIDs might protect MKN 28 cells against VacA-induced cytotoxicity by inhibiting VacA channel activity required for vacuole genesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12181162     DOI: 10.1152/ajpgi.00046.2002

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  2 in total

1.  Apple polyphenol extracts prevent damage to human gastric epithelial cells in vitro and to rat gastric mucosa in vivo.

Authors:  G Graziani; G D'Argenio; C Tuccillo; C Loguercio; A Ritieni; F Morisco; C Del Vecchio Blanco; V Fogliano; M Romano
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

2.  Identification of novel cyclooxygenase-2-dependent genes in Helicobacter pylori infection in vivo.

Authors:  Anna K Walduck; Matthias Weber; Christian Wunder; Stefan Juettner; Manfred Stolte; Michael Vieth; Bertram Wiedenmann; Thomas F Meyer; Michael Naumann; Michael Hoecker
Journal:  Mol Cancer       Date:  2009-03-24       Impact factor: 27.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.